anti-GD2 monoclonal antibody BCD-245
Term · Oncology and biomedicine · MLC-T-ONC-010686
A monoclonal antibody directed against the tumor-associated antigen (TAA) disialoganglioside (GD2; GD-2), with potential antineoplastic activity. Upon administration, anti-GD2 monoclonal antibody BCD-245 may induce cytotoxicity in GD2-expressing tumor cells by antibody-dependent cell-mediated cytotoxicity (ADCC). GD2 is overexpressed on the surface of neuroblastoma (NB) cells and by other neuroectoderm-derived neoplasms, while it is minimally expressed on normal cells.
| Identifier | MLC-T-ONC-010686 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-GD-2 monoclonal antibody BCD-245 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010686",
"term": "anti-GD2 monoclonal antibody BCD-245",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody directed against the tumor-associated antigen (TAA) disialoganglioside (GD2; GD-2), with potential antineoplastic activity. Upon administration, anti-GD2 monoclonal antibody BCD-245 may induce cytotoxicity in GD2-expressing tumor cells by antibody-dependent cell-mediated cytotoxicity (ADCC). GD2 is overexpressed on the surface of neuroblastoma (NB) cells and by other neuroectoderm-derived neoplasms, while it is minimally expressed on normal cells.",
"synonyms": [
"anti-GD-2 monoclonal antibody BCD-245"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-gd2-monoclonal-antibody-bcd-245/"
}
Record 1,789 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.